Search Results

Radexel leads South Korea's KRW 35.2 billion project to develop magnetically controlled radiotherapy equipment

South Korean medical device company Radexel announced on August 24 that it has been selected as the lead institution for a global flagship project, partnering with Asan Medical Center, the Korea Atomic Energy Research Institute (KAERI), and other organizations to develop next-generation radiotherapy equipment based on magnetic field control. The project is a national strategic R&D initiative jointly promoted by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety, with a total investment of KRW 35.2 billion, including KRW 27.95 billion in government funding, over a seven-year period. Under the plan, the Radexel consortium will develop a Magnetically Controlled Radiotherapy (MPRT) system. This technology controls secondary...

2026-08-24

IAEA imPACT Assessment Recommends Namibia Expand Cancer Diagnosis and Treatment Services

August 18, 2026, the results of the International Atomic Energy Agency's imPACT review show that Namibia has demonstrated a clear commitment to strengthening cancer treatment, while still needing to further expand service coverage, build the oncology workforce, and improve access to cancer diagnosis and treatment nationwide. Cancer is becoming an increasingly prominent public health challenge in Namibia. Data shows that the country records more than 4,200 new cancer cases annually. According to Globocan 2024 projections, this figure is expected to rise to 7,200 by 2040. Breast cancer, cervical cancer, prostate cancer, and Kaposi sarcoma currently account for nearly half of all confirmed cancer cases in Namibia...

2026-08-19

CGN Hezhi® Proton Therapy System Clinical Performance Successfully Passes Expert Review

On July 31, the expert review meeting for the clinical performance evaluation of the CGN Hezhi® Proton Therapy System was held at the CGN Proton Therapy Equipment Manufacturing Base. Clinical experts from Sun Yat-sen University Cancer Center, National Cancer Center/Cancer Hospital of Chinese Academy of Medical Sciences, Sichuan Cancer Hospital, National Cancer Center/Cancer Hospital of Chinese Academy of Medical Sciences Shenzhen Hospital, and Shandong First Medical University Affiliated Cancer Hospital attended the review meeting.▲Expert review of CGN Hezhi® Proton Therapy System clinical performanceAt the review meeting, the relevant person in charge of CGN Medical Technology Co., Ltd. (hereinafter referred to as the "Company") introduced that the comprehensive verification platform for the proton therapy system has achieved full-process independent controllability from design, procurement, production,...

2026-08-12

Han Bing, Chairman of Hefei Municipal CPPCC, Leads Delegation to CYC Ion for Research and Guidance

On the afternoon of August 4, Han Bing, Chairman of Hefei Municipal Committee of the Chinese People's Political Consultative Conference (CPPCC), led a delegation to CYC Ion for research and guidance, and held a symposium. Yong Fengshan, Deputy Director of the Standing Committee of the Municipal People's Congress; Su Xiang, Secretary-General of the Municipal CPPCC; Jiang Xin, Chairman of the Municipal Industrial Investment Group; Zhang Xiaofeng, Director of the Education, Science, Health and Sports Committee of the Municipal CPPCC; and Guo Mei, Deputy Director of the Municipal Bureau of Industry and Information Technology, participated in the event. Song Yuntao, Deputy Director of the Hefei Institutes of Physical Science, Chinese Academy of Sciences; Liu Lu, Chairman of CYC Ion; Chen Yonghua, General Manager; and Deputy General Managers Ding Kaizhong, Li Jun, and Guang Ruohuai accompanied the delegation. The delegation was briefed in detail on CYC Ion's industrial layout and business operations, with discussions focusing on key technological breakthroughs in nuclear medicine and high-end equipment, technology transfer and commercialization, and industrial development.

2026-08-06